DNA Probes-based Diagnostics Market Trajectory & Analytics to 2025 - ResearchAndMarkets.com

DUBLIN--()--The "DNA Probes-based Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The DNA Probes-based Diagnostics market worldwide is projected to grow by US$6.8 Billion, driven by a compounded growth of 5.8%.

Infectious Diseases, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$12.3 Billion by the year 2025, Infectious Diseases will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$318.4 Million to the region's size and clout in the next 5 to 6 years. Over US$316.5 Million worth of projected demand in the region will come from Rest of Europe markets.

In Japan, Infectious Diseases will reach a market size of US$965 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5.7% over the next couple of years and add approximately US$1.2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific.

All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Key Topics Covered

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of COVID-19 and a Looming Global Recession
  • What are DNA-Probes?
  • Recent Market Activity
  • DNA-based Diagnostics - A Prelude
  • DNA Tests: Finding Use in Numerous Applications
  • DNA Probes: Robust Growth Ahead
  • Developed Markets: Traditional Revenue Contributors
  • The United States: Unraveling the Country's Edge in DNA-based Diagnostics
  • Infectious Diseases Tests Dominate the DNA-based Diagnostics Market
  • Developing Countries Excel in Growth Prospects
  • Decoding the Genetic Puzzle
  • Growth Drivers in a Nutshell
  • Growth Inhibitors in a Nutshell
  • Genetic Profiling of Pathogens: A Road Less Traveled
  • Roche's Entry into the Hall of Molecular Fame
  • DNA Technology: An Evolutionary Scan
  • Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005
  • Market Opportunities
  • Global Competitor Market Shares
  • DNA Probes-Based Diagnostics Competitor Market Share Scenario Worldwide (in %): 2018 & 2029

2. FOCUS ON SELECT PLAYERS

  • Abbott Molecular (USA)
  • Beckman Coulter, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • bioMerieux (France)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • GE Healthcare Life Sciences (UK)
  • Luminex Corporation (USA)
  • QIAGEN N.V. (Netherlands)
  • Siemens Healthineers (Germany)
  • Thermo Fisher Scientific, Inc. (USA)

3. MARKET TRENDS & DRIVERS

  • World's Aging Population Drives the Popularity of DNA-Probe Tests
  • Global Aging Population Statistics - Opportunity Indicators
  • Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based Diagnostics
  • AIDS: A Global Epidemic
  • Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth
  • Reimbursements: 'Under the Umbrella'
  • Evolution of New & Virulent Infectious Agents
  • Challenges in Widespread Deployment of DNA-based Diagnostics
  • DNA Probe Technology Gains Prominence in Diagnosing Vaginitis
  • Gene Banks - A Ray of Hope for the Future

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/9lme4q

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900